Skip to content

ALPINE IMMUNE SCIENCES, INC.

CIK 0001626199

← back to feed
Revenue (TTM)
$35.06M
+95.8% YoY Q1 May 2024
Net Income (TTM)
−$56.06M
+44.3% YoY Q1 May 2024
EPS Diluted (TTM)
−$1.07
+63.0% YoY Q1 May 2024
Gross Margin
—
Q1 May 2024
Operating Margin
-195.4%
Q1 May 2024
Net Margin
-159.9%
Q1 May 2024
Free Cash Flow (TTM)
−$64.54M
Q1 May 2024
Cash
$33.02M
Q1 May 2024
Total Debt
$0
Q1 May 2024
Shares Outstanding
68.6M sh
Q1 May 2024

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings